Yonghe Medical's Share Repurchase Gets Results, But Can't Hide A Receding Profit Line
Key Takeaways:
Yonghe Medical’s gamble on growing demand for its hair transplant services led to losses in the second half of 2022 and first six months of 2023
A stock repurchase plan announced late last month propped up its shares, but the stock is still down by about three-quarters from its 2021 IPO price
